Lenacapavir
(GS-6207)Lenacapavir (GS-6207) is a HIV-1 capsid inhibitor. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells. Lenacapavir displays a mean EC50 of 50 pM (20-160 pM) against 23 HIV-1 clinical isolates from different subtypes in peripheral blood mononuclear cells (PBMCs).
Lenacapavir is intended for Pharmaceuticals applications and a first-in-class capsid inhibitor with a multi-stage mechanism of action to treat and prevent HIV infection. ChemExpress deliver compounds with high purity levels.
We can provide high-quality Lenacapavir and its derived impurities.
-
CAS2189684-44-2
-
CatalogHY-111964
-
Molecular Weight968.28
-
Molecular FormularC39H32ClF10N7O5S2
-
Tert-butyl (S)-(1-(3,6-dibromopyridin-2-yl)-2- (3,5-difluorophenyl)ethyl) carbamateCAS: 1620056-47-4 -
3-methyl-3-(methylsulfonyl) but-1-yneCAS: 2109226-54-0 -
1,1-Dimethylethyl N-[(1S)-1-[3-bromo-6-[3-methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]carbamateCAS: 2189684-54-4 -
4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amineCAS: 2189684-53-3 -
(3bS,4aR)-5,5-Difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acidCAS: 1620056-83-8
